SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-20-010816
Filing Date
2020-06-08
Accepted
2020-06-08 21:21:31
Documents
1
Period of Report
2020-06-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3958
  Complete submission text file 0001493152-20-010816.txt   5417
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Issuer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2042 CORTE DEL NOGAL SUITE B CARLSBAD CA 90211
Business Address
Lotz Christopher L. (Reporting) CIK: 0001812553 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37428 | Film No.: 20950770